Earliest physical trace of beer found at a site called Godin Tepe
The earliest physical trace of beer dates back to the late fourth millennium BC in present day Iran…
-
-
Animal Biosecurity and Agro-Defense Program launched at Auburn
On Oct. 2, 2021, the Auburn University College of Veterinary Medicine was announced as the home to the…
-
FDA approved Kiteﾒs Tecartusﾮ as first and only Car T for adults with Relapsed or Refractory B-cell ALL
On Oct. 1, 2021, Kite, a Gilead Company, announced the U.S. Food and Drug Administration had granted approval…
-
U.S. FDA cleared Naeotom Alpha, worldﾒs first photon-counting computer tomograph
On Sept. 30 2021, Siemens Healthineers announced the Food and Drug Administration (FDA) 510 (k) clearance of the…
-
Relief reported that collaboration partner announced a second favorable safety report for ZYESAMI(TM) in Patients with COVID-19
On Sept. 30, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals,…
-
VBI Vaccines announced preclinical data and Initiation of VBI-2905 clinical trial targeting broadened immunity against COVID-19
On Sept. 29, 2021, VBI Vaccines announced positive results from multiple preclinical studies against several COVID-19 variants of…
-
Colossal, a de-extinction company was founded to bring the Woolly Mammoth back to life
On Sept. 29, 2021, Colossal, a de-extinction company that is combining the science of genetics with the business…
-
Cepheid received Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV combination test
On Sept. 29, 2021, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
-
TGen part of $60 million grant awarded to UArizona to create national Precision Aging Network
On Sept. 28, 2021, TGen, an affiliate of City of Hope, will use its MindCrowd website portal to…
-
AIM ImmunoTech submitted pre-IND application to FDA for phase 2 clinical studies of Ampligen as potential therapeutic for COVID-19
On Sept. 28, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
-
University of Missouri researchers identified mutations of Delta, Delta Plus variants
On Sept. 28, 2021, the University of Missouri researcher Kamlendra Singh led a team that analyzed protein sequences…
-
Over half of U.S. children have detectable levels of lead in their blood in Quest Diagnostics study published in JAMA
On Sept. 28, 2021, Quest Diagnostics reported that one in two (50.5%) American children under six years of…
-
Soligenix announced publication demonstrating efficacy and broad neutralizing activity of its COVID-19 Vaccine
On Sept. 28, 2021, Soligenix announced publication of pre-clinical immunogenicity studies for CiVax (heat stable COVID-19 vaccine program)…
-
Pfizer and BioNTech submitted initial data to FDA from pivotal trial of COVID-19 vaccine in children 5 to <12 years of age
On Sept. 28, 2021, Pfizer and BioNTech announced they had submitted data to the U.S. Food and Drug…
-
Relief reported that collaboration partner announced improved survival in highly comorbid COVID-19 patients treated with ZYESAMITM
On Sept. 27, 2021, RELIEF THERAPEUTICS reported its U.S. collaboration partner, NRx Pharmaceuticals, had announced top line data…
-
Pfizer started global phase 2/3 EPIC-PEP study of novel COVID-19 oral antiviral candidate for post-exposure prophylaxis in adults
On Sept. 27, 2021, Pfizer announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for…
-
Twist Bioscience single domain antibody TB202-3 showed potent binding to multiple strains of SARS-CoV-2
On Sept. 23, 2021, Twist Bioscience reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to…
-
Pfizer and BioNTech received first U.S. FDA Emergency Use Authorization of a COVID-19 vaccine booster
On Sept. 23, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has authorized…
-
Clover Biopharmaceuticals’s vaccine using Dynavax’s CpG 1018 adjuvant met primary and secondary efficacy endpoints
On Sept. 22, 2021, Dynavax Technologies announced that Clover Biopharmaceuticals reported positive data for their protein-based COVID-19 vaccine…
-
The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
-
Pfizer and BioNTech announced positive topline results from pivotal trial of COVID-19 vaccine in children 5 to 11 years
On Sept. 20, 2021, Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety…
-
CDC to invest $2.1 billion to protect patients and healthcare workers from COVID-19 and future infectious diseases
On Sept. 17, 2021, the Centers for Disease Control and Prevention (CDC) announced a $2.1 billion investment to…
-
Great cats tested presumptive positive for COVID-19 at the Smithsonian’s National Zoo
On Sept. 17, 2021, the lions and tigers at the Smithsonian’s National Zoo were reported testing presumptive positive…
-
The COVID-19 pandemic has caused the biggest decrease in life expectancy since World War II
On Sept. 17, 2021, Oxfordﾒs Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…
-
Africa faced 470 million COVID-19 vaccine shortfall in 2021
On Sept. 16, 2021, the WHO reported that the continent faced almost 500 million doses short of the…
-
Celsion and Hainan Poly Pharm signed agreement to manufacture Celsionﾒs DNA-based vaccine
On Sept. 16, 2021, Celsion and Hainan Poly Pharm announced an amendment to their existing contract manufacturing agreement…
-
Oragenics initiated COVID-19 challenge study evaluating multiple formulations of its SARS-CoV-2 vaccine candidate
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
-
US Department of Defense awarded $3.2 billion in contract modifications for monoclonal antibodies
On Sept. 15, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
World global health leaders made urgent call to accelerate vaccination globally
On Sept. 14, 2021, the WHO Director General Dr Tedros Adhanom Ghebreyesus and a group of global health…
-
Misdirected antibodies linked to severe COVID-19
On Sept. 14, 2021, the NIH announced that an international project called the COVID Human Genetic Effort has…
